Heron Therapeutics Reaches Settlement Agreement with Mylan for CINVANTI and APONVIE Patent Disputes Heron Therapeutics has reached a settlement with Mylan regarding patent disputes over CINVANTI and APONVIE. Mylan can market generics starting June 2032.

Heron Therapeutics Reaches Settlement Agreement with Mylan for CINVANTI and APONVIE Patent Disputes #United_States #CARY #CINVANTI #Heron_Therapeutics #Mylan_Pharmaceuticals